Orthofix Medical Inc. vs UnitedHealth Group Incorporated — Stock Comparison
Q·Score Breakdown
6.3
Neutral
Overall
6.3
Neutral
Quality
Health
Growth
Valuation
Sentiment
OFIX
Clean balance sheet with low leverage (0.5× debt-to-equity).
⚠ currently unprofitable (-11% margin).
UNH
82% of 28 covering analysts have a positive rating.
⚠ limited growth momentum.
Analyst Consensus
BUY
Target $17.25 (+44.8%)
4 analysts
BUY
Target $387.27 (+5.0%)
26 analysts
Fundamentals
OFIX
UNH
—
Trailing P/E
27.9×
13.9×
Forward P/E
17.8×
-11.2%
Profit Margin
2.7%
68.8%
Gross Margin
18.8%
-19.3%
ROE
12.2%
2.0%
Revenue Growth
2.0%
—
Earnings Growth
0.7%
0.82
Beta
0.41
—
Price / Book
—
$481M
Market Cap
$334.9B
$10 – $17
52-Week Range
$235 – $410
Q·Score is an educational tool and is not financial advice. Data provided by Yahoo Finance. Updated on each page load. How it's calculated →